Companies that own TESARO Inc.
Wellington Management Co. LLP
5,203,108
9.48%
-2,368,801
0.03%
06/30/2018
Fidelity Management & Research Co.
4,921,968
8.96%
-2,507,130
0.02%
06/30/2018
Camber Capital Management LLC
3,500,000
6.37%
1,000,000
4.62%
08/03/2018
The Vanguard Group, Inc.
3,196,293
5.82%
69,043
0%
06/30/2018
T. Rowe Price Associates, Inc.
3,083,347
5.62%
88,750
0.01%
06/30/2018
Bellevue Asset Management AG
2,811,802
5.12%
359,750
1.32%
08/08/2018
BlackRock Fund Advisors
2,316,507
4.22%
19,408
0%
06/30/2018
SSgA Funds Management, Inc.
2,064,985
3.76%
303,571
0.01%
06/30/2018
Frontier Capital Management Co. LLC
1,764,417
3.21%
1,522,157
0.38%
06/30/2018
TIAA-CREF Investment Management LLC
1,074,513
1.96%
128,027
0.02%
06/30/2018
| Address |
1000 Winter Street
Waltham Massachusetts 02451
United States
|
|
Employees
|
- |
| Website |
http://www.tesarobio.com |
| Updated |
09/14/2018 |
| TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. It focuses on oncology-based therapeutics and its products include: Rolapitant and Niraparib. The company was founded by Leon Moulder, Jr. |
